Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms

被引:172
作者
Tafe, Laura J. [1 ]
Garg, Karuna [1 ]
Chew, Ivy [1 ]
Tornos, Carmen [2 ]
Soslow, Robert A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[2] SUNY Stony Brook, Med Ctr, Dept Pathol, New York, NY USA
关键词
endometrium; ovary; undifferentiated carcinoma; endometrioid carcinoma; DNA mismatch repair; malignant mixed Mullerian tumor; RHABDOID TUMOR; MORPHOLOGY; FEATURES; UTERUS;
D O I
10.1038/modpathol.2010.41
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Carcinomas of the endometrium and ovary with undifferentiated components are uncommon neoplasms that are likely underdiagnosed. They are important to recognize as they have been shown to be clinically aggressive. We identified 32 carcinomas with undifferentiated components as defined by Silva and co-workers, 26 endometrial and 6 of ovarian origin. The patient age ranged from 21 to 76 years (median 55); 40% of patients were <= 50 years of age. Most patients (58% of endometrial and 83% of ovarian carcinomas with undifferentiated components) presented at advanced stages (FIGO III-IV). Pelvic and para-aortic lymph nodes were the most frequent sites of metastases. Twenty tumors, entirely undifferentiated, consisted of sheets of dyshesive, ovoid cells with uniform, large vesicular nuclei, whereas 12 tumors contained combinations of differentiated endometrioid adenocarcinoma with undifferentiated components. Although most undifferentiated tumors had a monotonous cytologic appearance without prominent stroma, six showed focal nuclear pleomorphism and eight cases had variably sized zones of rhabdoid cells in a background of myxoid stroma. The tumors were frequently misdiagnosed; they received a wide range of diagnoses, including FIGO grade 2 or 3 endometrioid carcinoma, carcinosarcoma, high-grade sarcoma including endometrial stromal sarcoma, neuroendocrine carcinoma, lymphoma, granulosa cell tumor and epithelioid sarcoma. Up to 86% of the cases showed focal, but strong keratin and/or epithelial membrane antigen staining, with CK18 being the most frequently positive keratin stain. They were predominantly negative for neuroendocrine markers, smooth muscle markers and estrogen receptor/progesterone receptor. Mismatch repair protein expression by immunohistochemistry was evaluated in 17 cases, and 8 (47%) were abnormal (7 with loss of MLH1/PMS2 and 1 with MSH6 loss). Follow-up was available for 27 patients, although it was very short in many cases, ranging from 0.5 to 89 months (median 9 months). Eleven patients (41%) died of the disease in 0.5-20 months, four are alive with disease and twelve patients have no evidence of disease. Endometrial and ovarian carcinomas with undifferentiated components have a broad histologic differential diagnosis, but they show specific histologic features that should enable accurate diagnosis. These tumors can occur in young women, may be associated with microsatellite instability and behave in a clinically aggressive manner. Modern Pathology (2010) 23, 781-789; doi:10.1038/modpathol.2010.41; published online 19 March 2010
引用
收藏
页码:781 / 789
页数:9
相关论文
共 17 条
  • [1] Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor
    Al-Hussaini, Maysa
    Hirschowitz, Lynn
    McCluggage, W. Glenn
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (02) : 236 - 242
  • [2] Undifferentiated carcinoma of the endometrium
    Altrabulsi, B
    Malpica, A
    Deavers, MT
    Bodurka, DC
    Broaddus, R
    Silva, EG
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (10) : 1316 - 1321
  • [3] [Anonymous], 2003, WHO CLASSIFICATION T
  • [4] Pathologic features of endometrial carcinoma associated with HNPCC - A comparison with sporadic endometrial carcinoma
    Broaddus, RR
    Lynch, HT
    Chen, LM
    Daniels, MS
    Conrad, P
    Munsell, MF
    White, KG
    Luthra, R
    Lu, KH
    [J]. CANCER, 2006, 106 (01) : 87 - 94
  • [5] MALIGNANT RHABDOID TUMOR OF THE UTERUS
    CHO, KR
    ROSENSHEIN, NB
    EPSTEIN, JI
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1989, 8 (04) : 381 - 387
  • [6] Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium
    Donner, Ludvik R.
    Wainwright, Luanne M.
    Zhang, Fan
    Biegel, Jadyn A.
    [J]. HUMAN PATHOLOGY, 2007, 38 (06) : 935 - 939
  • [7] Prognostic features of surgical stage I uterine carcinosarcoma
    Ferguson, Sarah E.
    Tornos, Carmen
    Hummer, Amanda
    Barakat, Richard R.
    Soslow, Robert A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (11) : 1653 - 1661
  • [8] Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: A case report and review of the literature
    Gaertner, EM
    Farley, JH
    Taylor, RR
    Silver, SA
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1999, 18 (04) : 396 - 401
  • [9] Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities
    Garg, Karuna
    Leitao, Mario M., Jr.
    Kauff, Noah D.
    Hansen, Jessica
    Kosarin, Kristi
    Shia, Jinru
    Soslow, Robert A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (06) : 925 - 933
  • [10] Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors
    Hoot, AC
    Russo, P
    Judkins, AR
    Perlman, EJ
    Biegel, JA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) : 1485 - 1491